Onpattro 2 mg/ml, Konzentrat zur Herstellung einer Infusionslösung - Swissmedic Key 67304001 Registration Holder Alnylam Switzerland GmbH Name Onpattro 2 mg/ml, Konzentrat zur Herstellung einer Infusionslösung Date of registration 23.09.2019 Introduction of Sequence 23.09.2019 ATC-Classification Patisiran (N07XX12) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 01.99. Show package size Index Therapeuticus (Swissmedic) 01.99. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 7951.47 Limitation Yes Limitation text
Deductible 10 % Consumer price 8466.00 Feedback FB GTIN 7680673040010 Medication Code Transplantat: Gentherapieprodukt Pharmacode 7771641 Disponibility
Composition patisiranum 2 mg ut patisiranum natricum, DLin-MC3-DMA, 1,2-dimyristoyl-sn-glycero-3-carboxaminopropylmacrogoli 2000 aether methylicus, 1,2-distearoyl-sn-glycero-3-phosphocholinum, cholesterolum, dinatrii phosphas heptahydricus, kalii dihydrogenophosphas, natrii chloridum, aqua ad iniectabile natrium 3.99 mg, q.s. ad solutionem pro 1 ml corresp.. Packungsbestandteile Galenic Form Concentrate for infusion Excipiens Active Agent Dose Patisiranum 2 mg
BAG: Active Agent Dose Patisiranum 2 mg
Inactive agents Dose 1,2-dimyristoyl-Sn-Glycero-3-Carboxaminopropylmacrogoli 2000 1,2-distearoyl-Sn-Glycero-3-Phosphocholinum Aether Methylicus Cholesterol Disodium Phosphate Heptahydrate Dlin-Mc3-dma Potassium Dihydrogenophosphate Sodium Chloride
Source Data was imported : 06.12.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
